BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38148258)

  • 1. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
    Antunez AG; Kanters AE; Regenbogen SE
    JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.
    Swords DS; Skarda DE; Sause WT; Gawlick U; Cannon GM; Lewis MA; Scaife CL; Gygi JA; Tae Kim H
    J Gastrointest Surg; 2019 Apr; 23(4):659-669. PubMed ID: 30706375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer.
    Fong ZV; Chang DC; Hur C; Jin G; Tramontano A; Sell NM; Warshaw AL; Fernandez-Del Castillo C; Ferrone CR; Lillemoe KD; Qadan M
    Am J Surg; 2020 Jul; 220(1):29-34. PubMed ID: 32265013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Fragmentation of Care in Locally Advanced Rectal Cancer Increase Patient Mortality?
    Freischlag K; Olivere L; Turner M; Adam M; Mantyh C; Migaly J
    J Gastrointest Surg; 2021 May; 25(5):1287-1296. PubMed ID: 32754789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
    Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
    Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Commission on Cancer Accreditation Status, Hospital Rurality and Hospital Size on Quality Measure Performance Rates.
    Schroeder MC; Gao X; Lizarraga I; Kahl AR; Charlton ME
    Ann Surg Oncol; 2022 Apr; 29(4):2527-2536. PubMed ID: 35067792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Center Volume and Type Impact Stage-Specific Utilization of Neoadjuvant Therapy in Rectal Cancer.
    Midura EF; Jung AD; Daly MC; Hanseman DJ; Davis BR; Shah SA; Paquette IM
    Dig Dis Sci; 2017 Aug; 62(8):1906-1912. PubMed ID: 28501970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Verm RA; Baker MM; Cohn T; Park S; Swanson J; Freeman R; Abdelsattar ZM
    Surgery; 2024 Mar; 175(3):618-628. PubMed ID: 37743107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
    Becerra AZ; Wexner SD; Dietz DW; Xu Z; Aquina CT; Justiniano CF; Swanger AA; Temple LK; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2018 Aug; 25(8):2332-2339. PubMed ID: 29850952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmented Care in the Treatment of Rectal Cancer and Time to Definitive Therapy.
    Abelson JS; Bauer PS; Barron J; Bommireddy A; Chapman WC; Schad C; Ohman K; Hunt S; Mutch M; Silviera M
    J Am Coll Surg; 2021 Jan; 232(1):27-33. PubMed ID: 33190785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
    Freischlag K; Sun Z; Adam MA; Kim J; Palta M; Czito BG; Migaly J; Mantyh CR
    JAMA Surg; 2017 Jun; 152(6):558-564. PubMed ID: 28273303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.
    Swords DS; Brooke BS; Skarda DE; Stoddard GJ; Tae Kim H; Sause WT; Scaife CL
    J Gastrointest Surg; 2019 Jun; 23(6):1206-1217. PubMed ID: 30421120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.